In January 1992 he reported depressed libido and initial investigations showed low levels of serum testosterone. An endocrinologist then noticed that he appeared myxoedematous, overweight and pale with loss of axillary and body hair. The testes were small (8mL bilaterally) and soft. Serum testosterone was low at 3.3 nmol/L (normal 11-36); follicle stimulating hormone, luteinizing hormone, and prolactin were all within normal limits (1.1 IU/L, 2.0 IU/L, 170 mU/L) but free thyroxine was low at 9.3 pmol/L in the setting of a normal thyroid stimulating hormone at 1.6mU/L (0.5-4.5). A corticotropin test showed peak cortisol level of 390 nmol/L. In view of this low response an insulin tolerance test was done: in the face of adequate and symptomatic hypoglycaemia peak plasma cortisol was 490nmol/L and maximum serum growth hormone was 1.3mU/L. Computed tomographic scan of the pituitary gland was normal. From these tests it was concluded that he had anterior pituitary failure. He was treated with hydrocortisone 20 mg in the morning and 10mg in the evening, L-thyroxine 100 jig daily, and intramuscular Sustanon (a testosterone preparation) 250mg every three weeks. During follow-up he improved from the endocrine aspect and the leukaemia remained in remission. COMMENT The first possible complication of his treatment was the fracture to his femur. Perhaps it was due to steroidinduced osteoporosis but this becomes less likely when we see that he continued steroids for two years without further bone troubles. What of the pituitary failure (hypogonadism, hypoadrenalism, growth hormone deficiency, hypothyroidism) that developed six years later?
This might have been a late manifestation of damage due to the leukaemia itself3; or it might have been fortuitous, unrelated to the leukaemic episode. We suspect, however, that it was connected with the treatment of the leukaemia. The treatment most often implicated in pituitary failure is radiotherapy to the brain; however, this is usually given with intrathecal methotrexate so analysis of their separate contributions is difficult4. In adults treated for brain or pituitary tumours, radiotherapy related hypopituitarism is well documented5 but this is not true of adults wvith acute lymphoblastic leukaemia. Since the onset is usually insidious and the treatment is very rewarding, we would encourage suitable investigations in long-term survivors of acute leukaemia who have suspicious symptoms. If similar cases are reported in the future further research may be needed. dysfunction after radiation for brain tumours. N Engi J Depot antipsychotics are used in the maintenance treatment of schizophrenia, bipolar affective disorder and organic psychoses. They can also be used to manage non-psychotic behavioural disturbance in selected patients with learning disability, dementia and personality disorder. Administration by community psychiatric nurses or in special 'depot clinics' has long been practised and depot antipsychotics are increasingly given by general practitioners and practice nurses in liaison with community psychiatric teams. Depot antipsychotics are long-acting drug preparations whose adverse effects can be difficult to reverse. They should be initiated only after careful assesssment and should form part of individually tailored treatment plans where the patient's physical and mental state will be monitored closely. received Depixol (flupenthixol decanoate) injections in the past. Prison medical staff saw no evidence of psychosis, but took the patient's history on trust and began flupenthixol decanoate injections, 80mg every two weeks. After two doses he developed severe extrapyramidal side-effects in the form of parkinsonism with marked tremor. These increased in severity over the next two weeks, and were unresponsive to treatment with anticholinergic medication in the remand prison.
He was then admitted to a district general hospital complaining of chest pain, which was diagnosed as angina. There psychiatric assessment revealed no evidence of psychotic or affective disorder. Cognitively he was oriented, he performed well on tests of short-term memory and concentration, and there was no suggestion of approximate answers as seen in Ganser's syndrome. His main preoccupations were with the severe extrapyramidal side-effects, and about where he would go when he left the hospital (the charges against him having been dropped). His tremor rendered him unable to eat or drink unaided, and he was so immobile that a pressure area developed on his left heel.
He was vague about much of his personal history but gave the impression he had travelled widely in Britain, was poorly educated, and had an extensive forensic history. He specifically named three psychiatric hospitals where he claimed to have received inpatient or outpatient depot antipsychotic treatment. One had no record of him (under either of the two surnames he gave), one proved to be a psychogeriatric unit that had never had a remit for the treatment of general adult psychiatric patients and one proved fictitious. The outpatient unit responsible for administering depots in the area he specified had no record of him.
During a twenty-four-day admission to the district general hospital his parkinsonism resolved fully with anticholinergic medication. Two further psychiatric assessments during this period yielded no evidence of psychosis, so further antipsychotic treatment was withheld. He had no further episodes of chest pain and was discharged from the district general hospital to a local hostel for psychiatric patients. At three-month follow-up there was still no evidence of psychotic or affective disorder. He remained vague about personal details, and gave the impression of deliberate evasiveness rather than selective amnesia. His level of self-care and general functioning appeared entirely normal, with no evidence of cognitive impairment. He reluctantly gave the address of a relative, but this proved fictitious. After being caught shoplifing on two occasions he packed his belongings and left the hostel without trace.
Case 2
A man aged 28 was admitted under a medical team with a generalized extrapyramidal stiffness, sweating and urinary incontinence. His creatine phosphokinase level was 2120 IU/L and neuroleptic malignant syndrome was diagnosed. He told the admitting physicians he had been diagnosed as having schizophrenia, and was on regular 'injections'.
Medical notes from the same hospital revealed that this was his second episode of neuroleptic malignant syndrome. A year earlier he had had a two-month admission with neuroleptic malignant syndrome, and because of severe parkinsonian symptoms he had been treated with a brief course of levodopa.
Past psychiatric notes were available and revealed five previous contacts with the local psychiatric service three assessments after overdose, one outpatient review, and one psychiatric assessment for a court report. Continuity of care had proved difficult because he had regularly changed his address and/or general practitioner, and at times had left the area completely. His three overdoses all seemed to have been impulsive episodes related to arguments with friends or family. None of his overdose assessments had shown evidence of psychotic or affective disorder.
On the last overdose assessment, just eighteen days before admission with his second episode of neuroleptic malignant syndrome, he had falsely told the assessing psychiatrist he had schizophrenia and was on Modecate (fluphenazine decanoate) injections. He had also mentioned a local psychiatric hospital and consultant by name. It was only later when follow-up was being arranged that the psychiatrist realized he had been misled. The court report done six months earlier had noted an extensive forensic history stretching back to his teens, and had come to the conclusion that he was of low intelligence but had no definite psychiatric illness.
Subsequent enquiries revealed he had temporarily registered with a general practitioner in another part of Britain and told him he had schizophrenia and that he was on Modecate depot. He had then received a total of 150 mg fluphenazine decanoate in two injections over two weeks before leaving the area. The last depot injection had been given twenty days before his admission to hospital with his second episode of neuroleptic malignant syndrome. He responded well to conservative management, and after eleven days discharged himself against medical advice.
COMMENT
Although the medical diagnoses of iatrogenic parkinsonism and neuroleptic malignant syndrome were readily established, the psychiatric diagnoses of these patients are still unclear. Possible diagnoses include malingering (feigning psychological symptoms for external incentives), factitious disorder (feigning psychological symptoms for obscure,
week-long history of confusion, tremor, high temperature, internal psychological incentives), and unspecified psychotic disorder1.
Two studies of patients diagnosed as having 'feigned psychosis' showed at ten to twenty year follow-up that many individuals had subsequently been rediagnosed as having schizophrenia or an affective psychosis2'3. These reports should be interpreted with caution since they are retrospective and the numbers are small. Also, because it is easier to capture data about patients rereferred to psychiatric services because of psychosis, but difficult to identify what has happened to patients who have not been readmitted to mental health services, a selection bias may be operating. However, these observations do suggest that some patients who seem to feign psychotic disorders do so as part of a prodromal phase of a genuine psychotic illness.
Secondly, whatever the underlying psychiatric diagnosis, it is clear that both patients misled doctors into inappropriately prescribing depot antipsychotic treatment. In case 1 this led to a long hospital admission requiring intensive nursing input. In case 2, the treatment caused a second episode of a potentially fatal illness, neuroleptic malignant syndrome4. In case 2 the first protracted episode of neuroleptic malignant syndrome is also likely to have been caused by the inappropriate administration of a depot antipsychotic.
Thirdly, the two cases had features in commonconstant changes of address/general practitioner; limited educational achievement; extensive forensic history; knowledge of specific psychiatric medications; a superficial knowledge of psychiatric services (names of consultants or hospitals). When an unknown patient requests depot antipsychotic medication, the presence of these features might act as warning to take particular care.
Relapse in patients with a chronic psychosis on depot medication tends to occur in weeks or months, not hours or days after stopping antipsychotic drugs. Antipsychotic drugs are detectable in blood or tissues up to twelve months after a depot is discontinued. Patients with a chronic psychosis should be able to give a history of acute episodes of psychotic illness with symptoms such as hallucinations and delusions. Corroborative history from psychiatric hospitals or general practitioner notes should be obtained before a depot is given. Short courses of oral antipsychotics could be prescribed to an unfamiliar patient claiming to have a psychotic disorder while information is being sought.
Oral self-mutilation masquerading as malignancy Factitious disorders are those in which illness is simulated to gain attention and admission to hospital. This is often repetitive in nature, patients demonstrating considerable skill in convincing clinicians of the need for treatment1.
We report a child who presented with severe oral ulceration initially diagnosed as lymphatic lymphoma.
CASE HISTORY
A 9-year-old girl was referred to Guy's Dental Hospital because of the unusual appearance of her gingivae. The presenting complaint was of 'sore gums' in the upper right side of the mouth. It was volunteered that this had occurred elsewhere in the mouth over several months.
The patient had a clear medical history. The gingivae were ulcerated with inflammation crossing the mucogingival junction ( Figure 1 ). There was no lymphadenopathy. Aetiological factors such as nail-biting or over-zealous toothbrushing were considered but denied by the patient. Advice was to be very careful to brush the teeth gently. A preliminary haematological screen was normal. Two weeks later, at review, the gingivae were severely ulcerated. In view of the continuing severe pain, with malaise and substantial loss of school time, it was decided to perform a soft tissue biopsy. Because of poor cooperation this was 
